Showcases Stock ranks Forex

Ginkgo Bioworks Hldgs Inc (DNA)
3.24  0.17 (5.54%) 08-08 16:00
Open: 3.09 Pre. Close: 3.07
High: 3.3 Low: 3.02
Volume: 31,723,270 Market Cap: 5,775M
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 3.304 - 3.316 3.316 - 3.326
Low: 2.989 - 3.003 3.003 - 3.015
Close: 3.217 - 3.241 3.241 - 3.26
Stock Technical Analysis
Target: Six months: 3.97
One year: 4.64
Support: Support1: 2.89
Support2: 2.58
Resistance: Resistance1: 3.40
Resistance2: 3.97
Pivot: 2.98
Moving Averages: MA(5): 3.08
MA(20): 2.99
MA(100): 3.09
MA(250): 6.76
MACD: MACD(12,26): 0.04
Signal(12,26,9): 0.02
%K %D: %K(14,3): 73.15
%D(3): 66.51
RSI: RSI(14): 59.46
52-Week: High: 15.864
Low: 2.09
Change(%): -67.5
Average Vol(K): 3-Month: 22778
10-Days: 17047
Price, MAs and Bollinger Bands
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.

[ DNA ] has closed below upper band by 13.2%. Bollinger Bands are 44.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 11 bars. This is a sign that the market may be about to initiate a new trend.
Stock chart
Stock News
Fri, 05 Aug 2022
TopNewsGuide: Health and Biotech Surging on This Week's Announcements (WHSI, DNA, CEMI, AEMD, EJH) -

Thu, 04 Aug 2022
Should You Accumulate Ginkgo Bioworks Holdings Inc (DNA) Stock Thursday Morning? - InvestorsObserver

Thu, 28 Jul 2022
Will Ginkgo Bioworks Holdings Inc (DNA) Stay at the Top of the Healthcare Sector? - InvestorsObserver

Tue, 26 Jul 2022
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Mon, 25 Jul 2022
Ginkgo Bioworks to Buy Zymergen in $300 Million Stock Swap >DNA ZY - MarketWatch

Mon, 18 Jul 2022
Ginkgo Bioworks Announces Latest Collaboration for Beauty and Personal Care Industry with Sumitomo Chemical - PR Newswire

Financial Analysis
Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 1190.00
Shares Float (M) 753.84
% Held by Insiders 6.53
% Held by Institutions 77.44
Shares Short (K) 144640
Shares Short Prior Month (K) 109920
Stock Financials
EPS -1.672
Book Value (p.s.) 0.980
Profit Margin
Operating Margin -558.09
Return on Assets (ttm) -113.2
Return on Equity (ttm) -234.3
Qtrly Rev. Growth 281.9
Gross Profit (p.s.) 0.155
Sales Per Share 0.368
EBITDA (p.s.) -2.025
Qtrly Earnings Growth
Operating Cash Flow (M) -225.58
Levered Free Cash Flow (M) 682.11
Stock Valuation
PE Ratio -1.94
PEG Ratio
Price to Book value 3.31
Price to Sales 8.80
Price to Cash Flow -17.09
Stock Dividends
Dividend Yield
Dividend Growth

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android